Urinary sodium balance in patients with cirrhosis: Relationship to quantitative parameters of liver function

Hepatology

Volumn 26, Issue 5, 1997, Pages 1149-1155

  Wensing, Georg ^a,c   Lotterer, Erich ^a,b   Link, Irene ^a   Hahn, Eckhard G ^a   Fleig, Wolfgang E ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; CHRONIC LIVER DISEASE; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER CELL; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SODIUM INTAKE; SODIUM URINE LEVEL;

EID: 0030663533     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260510     Document Type: Article

References (35)

1. Wensing G, Sabra R, Branch RA. The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function. HEPATOLOGY 1990;11:779-786.
2. Wensing G, Sabra R, Branch RA. Renal and systemic hemodynamics in experimental cirrhosis in the rat. Relation to hepatic function. HEPATOLOGY 1990;12:13-19.
3. Wensing G, Sabra R, Branch RA. Relationship between oxidative hepatic metabolism, urinary sodium excretion and sympathetic nerve activity in experimental cirrhosis in the rat. Z Gastroenterol 1995;33:1-4.
4. Wensing G, Branch RA. Phenobarbital influences the onset of sodium retention in liver disease induced by bile duct ligation in the rat. HEPATOLOGY 1990;11:773-778.
5. Ohno T, Sabra R, Branch RA. Sodium retention and hepatic function after two-thirds partial hepatectomy in the rat. HEPATOLOGY 1991;14: 511-517.
6. Ohno T, Branch RA, Sabra R. Sodium retention and hepatic function following partial portal vein ligation in the rat. J Hepatol 1993;18:235-243.
7. Alvestrand A, Bergström J. Glomerular hyperfiltration after protein ingestion, during glucagon infusion, and in insulin-dependent diabetes is induced by a liver hormone: deficient production of this hormone in hepatic failure causes hepatorenal syndrome. Lancet 1984;II:195-197.
8. Wood LJ, Massie D, McLean AJ, Dudley FJ. Renal sodium retention in cirrhosis: tubular site and relation to hepatic dysfunction. HEPATOLOGY 1988;8:831-836.
9. Wong F, Massie D, Hsu P, Dudley F. Renal response to a saline load in well-compensated alcoholic cirrhosis. HEPATOLOGY 1994;20:873-881.
10. Wong F, Logan A, Blendis L. Systemic hemodynamic, forearm vascular, renal and humoral responses to sustained cardiopulmonary baroreceptor deactivation in well-compensated cirrhosis. HEPATOLOGY 1995;21: 717-724.
11. Wong F, Liu P, Allidina J, Blendis L. Pattern of sodium handling and its consequences in patients with preascitic cirrhosis. Gastroenterology 1995;108:1820-1827.
12. Bernardi M, Trevisani F, Santini C, de Palma R, Ligabue A, Gasparrini G. Aldosterone related blood volume expansion in cirrhosis before and after the early phase of ascites formation. Gut 1983;24:761-766.
13. Wong F, Liu P, Tobe S, Morali G, Blendis LM. Central blood volume in cirrhosis: measurement by radionuclide angiography. HEPATOLOGY 1994;19:312-321.
14. Rector WG Jr, Lewis F, Robertson AD, Everson GT. Renal sodium retention complicating alcoholic liver disease: relation to portosystemic shunting and liver function. HEPATOLOGY 1990;12:455-459.
15. Sungaila I, Bartle WR, Walker SE, DeAngelis C, Uetrecht J, Pappas C, Vidins E. Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. Gastroenterology 1992;102:1680-1685.
16. 14C-aminopyrine. Digestion 1988;39:241-250.
17. Leevy CM, Mendenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. J Clin Invest 1962;41:1169-1179.
18. Tygstrup N. Determination of the hepatic elimination capacity of galactose by single injection. Scand J Clin Lab Invest 1966;18(Suppl 92): 118-125.
19. Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, et al. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 1988;95:749-759.
20. Schnegg M, Lauterburg BH. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance. J Hepatol 1986;3:164-171.
21. Paumgartner M. The handling of indocyanine green by the liver. Schw Med Wschr 1975;105:(Suppl):1-30.
22. Brody DH, Leichter L. Clearance tests of liver function. Med Clin North Am 1979;63:621-630.
23. Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock SH. The electroencephalograph in liver disease. Lancet 1957;2:867-871.
24. Wensing G, Lotterer E, Ahlsdorff H, Kügler CFA, Hahn EG, Fleig WE. Relationship of the aminopyrine breath test and the Child-Pugh score to urinary sodium retention in patients with liver cirrhosis. Z Gastroenterol 1995;33:150-154.
25. Farrel GC, Cooksley WGE, Powell LW. Drug metabolism in liver disease. Clin Pharm Ther 1979;26:483-492.
26. Reichen J, Arts B, Schafroth U, Zimmermann A, Zeltner THB, Zysset T. Aminopyrine N-demethylation by rats with liver cirrhosis. Gastroenterology 1987;93:719-726.
27. Preisig R. Fremdsubstanzen als Indikatoren der Leberfunktion. Schweiz Med Wschr 1985;19(Suppl):36-42.
28. Skak C, Keiding S. Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver 1987;7:155-162.
29. Epstein M. The kidney in liver disease. In Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA, eds. The Liver. Biology and Pathobiology. Ed 3. New York: Raven, 1994:1235-1256.
30. Guengerich FP, Turvy CG. Comparison of levels of several human microsomal cytochrom P-450 enzymes and epoxide hydroxylase in normal and disease states using immunochemical of surgical liver samples. J Pharmacol Exp Ther 1991;256:1189-1194.
31. Meyer B, Luo H, Bargetzy M, Renner EL, Powell LW. Quantitation of intrinsic drug metabolizing capacity in human liver biopsy specimen: support for the intact hepatocyte theory. HEPATOLOGY 1991;13:475-481.
32. Lown K, Kolars J, Turgeon K, Merion R, Wrighton SA, Watkins PB. The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease. Clin Pharmacol Ther 1992;51:229-238.
33. George J, Murray M, Byth K, Farrel CF. Differential alteration of cytochrome P450 enzymes in livers from patients with severe chronic liver disease. HEPATOLOGY 1995;21:120-128.
34. Wong F, Massie D, Colman J, Dudley F. Glomerular hyperfiltration in patients with well compensated alcoholic cirrhosis. Gastroenterology 1993;104:884-889.
35. Bernardi M, Trevisani F, de Palma R, Ligabue A, Capani F, Baraldini M, Gasparrini G. Chronobiological evaluation of sympatho-adrenergic function in cirrhosis. Gastroenterology 1987;93:1178-1186.